Behzad Aghazadeh's most recent trade in Scribe Therapeutics Inc. was a trade of 2,333,333 Common Stock, par value $0.0001 per share done at an average price of $15 . Disclosure was reported to the exchange on July 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Scribe Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 24 Jul 2026 | 2,333,333 | 3,030,983 | - | 15 | 34,999,995 | Common Stock, par value $0.0001 per share |
| Scribe Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Purchase of securities on an exchange or from another person at price $ 22.31 per share. | 24 Jul 2026 | 50,000 | 3,080,983 | - | 22.3 | 1,115,500 | Common Stock, par value $0.0001 per share |
| Scribe Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Purchase of securities on an exchange or from another person at price $ 18.25 per share. | 24 Jul 2026 | 7,905 | 3,088,888 | - | 18.2 | 144,266 | Common Stock, par value $0.0001 per share |
| Scribe Therapeutics Inc | Behzad Aghazadeh | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 14,725 | 14,725 | - | - | Stock Option (Right to Buy) | |
| Whitehawk Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2026 | 38,040 | 38,040 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 40,006 | 40,006 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 8,333,000 | 8,333,000 | - | - | Pre-funded Warrant (right to buy) | |
| Whitehawk Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,832 | 45,832 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 28,255 | 28,255 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 22 Sep 2022 | 1,260,000 | 3,471,752 | - | 12.5 | 15,750,000 | Common Stock, $0.0001 par value per share ("Common Stock") |
| Whitehawk Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,573 | 18,573 | - | - | Stock Option (right to buy) |